Prostate Cancer Patients clinical trials

Explore recruiting prostate cancer patients clinical trials.

Recruiting prostate cancer patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prostate Cancer Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Short versus long-term androgen deprivation therapy combined with salvage radiotherapy in prostate cancer patients with biochemical recurrence after prostatectomy: a multicentre phase III randomised controlled trial

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open-label, multi-center, phase I/II study of GVV858 as a single agent and in combination with endocrine therapy in patients with advanced hormone receptor positive, HER2-negative breast cancer and other advanced solid tumors

Italy, Germany, France, Czechia, Denmark, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An open label, single-arm, phase 2 study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in high-risk prostate cancer patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Radiometabolic Therapy (RMT) with 177Lu PSMA in PSMA PET/CT positive advanced/metastatic tumours: a basket trial (LUBASKET)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastasis-directed therapy for oligorecurrent prostate cancer : A randomized phase III trial.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prostate Cancer Patients trials by city

Prostate Cancer Patients in Toronto Prostate Cancer Patients in Vancouver Prostate Cancer Patients in Montreal Prostate Cancer Patients in Calgary Prostate Cancer Patients in Edmonton Prostate Cancer Patients in Ottawa Prostate Cancer Patients in Winnipeg Prostate Cancer Patients in Quebec City Prostate Cancer Patients in Hamilton Prostate Cancer Patients in Kitchener Prostate Cancer Patients in London Prostate Cancer Patients in Halifax Prostate Cancer Patients in New York Prostate Cancer Patients in Los Angeles Prostate Cancer Patients in Chicago Prostate Cancer Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease